Inhibition of heregulin signaling by an aptamer that preferentially binds to the oligomeric form of human epidermal growth factor receptor-3.
about
A mathematical analysis of SELEXNeutralizing aptamers from whole-cell SELEX inhibit the RET receptor tyrosine kinaseAptamers: A promising chemical antibody for cancer therapyNucleic acid aptamers: research tools in disease diagnostics and therapeuticsBiosafe nanoscale pharmaceutical adjuvant materialsNucleic acid aptamers: an emerging frontier in cancer therapyAptamer-Drug ConjugatesInhibition of cell proliferation by an anti-EGFR aptamerRNA aptamers generated against oligomeric Abeta40 recognize common amyloid aptatopes with low specificity but high sensitivityCell-specific aptamers for targeted therapies.Recruitment of the adaptor protein Grb2 to EGFR tetramers.Quantitative selection of DNA aptamers through microfluidic selection and high-throughput sequencing.Selection of Nucleic Acid Aptamers Targeting Tumor Cell-Surface Protein BiomarkersIn vitro selection of RNA aptamer and specific targeting of ErbB2 in breast cancer cells.Aptamers that preferentially bind type IVB pili and inhibit human monocytic-cell invasion by Salmonella enterica serovar typhi.Kinase-mediated quasi-dimers of EGFRRapid identification of cell-specific, internalizing RNA aptamers with bioinformatics analyses of a cell-based aptamer selectionConformational changes in quadruplex oligonucleotide structures probed by Raman spectroscopyAptamer to ErbB-2/HER2 enhances degradation of the target and inhibits tumorigenic growth.Aptamers: versatile probes for flow cytometry.Local neutral networks help maintain inaccurately replicating ribozymesHi-Fi SELEX: A High-Fidelity Digital-PCR Based Therapeutic Aptamer Discovery Platform.Compounds identified by virtual docking to a tetrameric EGFR extracellular domain can modulate Grb2 internalization.A structural perspective on the regulation of the epidermal growth factor receptor.Pari passu dimers of dimers.Functional isolation of activated and unilaterally phosphorylated heterodimers of ERBB2 and ERBB3 as scaffolds in ligand-dependent signaling.RNA aptamer-based functional ligands of the neurotrophin receptor, TrkBCurrent progress of RNA aptamer-based therapeutics.Nanoparticle-aptamer bioconjugates for cancer targeting.Identification of an aptamer through whole cell-SELEX for targeting high metastatic liver cancers.Aptamers that recognize drug-resistant HIV-1 reverse transcriptaseThe role of ErbB3 and its binding partners in breast cancer progression and resistance to hormone and tyrosine kinase directed therapies.The ERBB3 receptor in cancer and cancer gene therapyReceptor and channel heteromers as pain targets.Aptamers in immunotherapy.Dynamic analysis of the epidermal growth factor (EGF) receptor-ErbB2-ErbB3 protein network by luciferase fragment complementation imagingHigher-order association states of cellular ERBB3 probed with photo-cross-linkable aptamers.The chemical biology of aptamers.Nucleic acid aptamers for targeting of shRNA-based cancer therapeutics.The selection of aptamers specific for membrane molecular targets.
P2860
Q24643926-DEE9F9E8-4AE9-414C-B783-5276D784A02CQ24803451-1D52DB76-7BB3-4B79-861C-8BC3332E53CFQ26766832-F25157DF-5367-49D2-A5EA-0C8585448BF3Q26824321-8A350CCB-F2F5-4AC1-AB88-A669B110FC85Q26829798-94B73A70-BB8A-446A-BFD8-4C80C310D4EEQ26849947-610E306D-85E9-4E66-82E7-014ABA21F20DQ28468281-2725792C-8D95-476C-8684-95F7335B7353Q28743866-405FB516-B0C7-4010-8886-9F4B5C0054ACQ30879431-B23D7D3B-2C63-4D3B-B804-B3775578B17DQ33432043-C36D8D73-3D76-4A0F-B867-08600475B173Q33566959-66BA496E-3BF1-48B9-A4BA-9CCC8307334FQ33655937-83DA3C21-358C-42BA-9A05-8DC67A5A9CEBQ33832781-D391E4F9-0F43-443E-9DB3-020A8D685127Q33958666-8A9FC2A8-FF31-436E-A6D8-131B37B47845Q34077138-4DDD22A6-274B-47E4-BAB7-0A3FC62B3FB4Q34352792-D04F5F0A-555F-46E9-ADBB-CC4F898E15DBQ34409758-9FEEBC5C-C843-4C5A-AE61-904A41C6F9BCQ34571647-81975B9C-A34A-4F98-B564-822CCAE22B22Q34695253-D53D2031-D49F-4617-900A-EB11709F3D7CQ34803826-AF5333A7-851A-47B9-B6F8-30BB67F5AC9DQ35316425-AF5CF6D0-95FF-41AA-935D-2AD7F3C585A0Q35569583-DEA5D71B-824F-4DC2-8F1F-63E13995109CQ35643021-025B993A-50C1-47BE-A4CB-679E36DAEFC6Q35674768-E10AFC8A-D405-4526-9B17-1F6AD2C49370Q36170761-4333D119-C06D-40E7-B939-C820E0AAD64EQ36170837-0D55A21F-BB4B-495D-BA58-53AD99B9C9D2Q36294425-D7CAA629-79FD-48A1-B8EE-D7A1B082C995Q36365202-146C2A60-1BA5-4E67-AACD-C3C89BD7B6DDQ36460842-562D772E-A4DD-41EC-8C0D-3AE2C39B781EQ36946778-2C9477E5-D121-4580-9A38-B51D7D100938Q36986716-4C27DD8F-4A97-44FE-A898-158D81CD6AF6Q37006174-2A900245-E3A3-4777-9B76-64F4F628C35FQ37135372-D4E7925E-FFF3-449C-9073-4A87AE769585Q37148710-129B3EB7-B07F-4133-85C3-54E1C03A32E3Q37160512-3DA1DC1B-07D2-471D-AFEC-8AEAF3785F5BQ37234153-ACECD304-9335-4CBD-AFEA-CC42BBDE7B31Q37355330-8DB548B2-250C-469E-A498-252BB8DCD494Q37423243-A481EE07-93B9-4EB7-9A36-9ADC0018AC2EQ37586838-47D6F65B-137C-458D-A5C2-D683489C02CCQ37768365-4F62B152-BBDE-4B0E-AA54-F32E74DCE59D
P2860
Inhibition of heregulin signaling by an aptamer that preferentially binds to the oligomeric form of human epidermal growth factor receptor-3.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Inhibition of heregulin signal ...... rmal growth factor receptor-3.
@ast
Inhibition of heregulin signal ...... rmal growth factor receptor-3.
@en
type
label
Inhibition of heregulin signal ...... rmal growth factor receptor-3.
@ast
Inhibition of heregulin signal ...... rmal growth factor receptor-3.
@en
prefLabel
Inhibition of heregulin signal ...... rmal growth factor receptor-3.
@ast
Inhibition of heregulin signal ...... rmal growth factor receptor-3.
@en
P2093
P2860
P356
P1476
Inhibition of heregulin signal ...... rmal growth factor receptor-3.
@en
P2093
Chi-Hong B Chen
George A Chernis
Ralf Landgraf
Van Q Hoang
P2860
P304
P356
10.1073/PNAS.1332660100
P407
P577
2003-07-21T00:00:00Z